EU European Structural & Investment Funds COMPETE 2020


POINT4PAC aims to develop a platform for discovery and early development of innovative technologies, therapies, and solutions for treatment, prevention and control of cancer. We combine complementary state-of-the art resources in phenotypic high throughput screening and medicinal chemistry, with antibody-drug conjugate technology and nanoparticle-engineered formulation for delivery to the right target in the right cell.

Funding European Structural & Investment Funds through the COMPETE Programme and National Funds through FCT – Fundação para a Ciência e a Tecnologia
Call/Topic 03/SAICT/2015 – Programas de Atividades Conjuntas
Project ref. 0019
Title Precision Oncology by Innovative Therapies and Technologies
Start date 1 January 2017
Duration 36 months
Total cost EUR 2 405 032,23
Project Coordinator Cecília M. P. Rodrigues
Project Beneficiaries iMed.ULisboa, Faculty of Pharmacy, University of Lisbon
MARE, Universidade de Coimbra and Instituto Politécnico de Leiria
CQE, IST-University of Lisbon
INESC-MN, IST-University of Lisbon
CQFM, IST-University of Lisbon
CIISA, Faculty of Veterinary Medicine, University of Lisbon
Project Partners Hospital Beatriz Ângelo, Loures
Hospital da Luz, Lisboa
Hovione SA, Portugal
Technophage SA, Portugal
GEDII – Grupo de Estudos da Doença Inflamatória Intestinal
APDII – Associação Portuguesa de Doentes com Doença Inflamatória do Intestino